At the Centre for Early Brain Development (CEBRA) we investigate how to promote optimal brain development in children who have been subjected to adverse events in the womb, during birth, or early childhood.
In our research we try to find causes of such events, preventative measures and treatment that can prevent and/or reduce the brain injury and the consequences of damage on neurodevelopment. The research includes animal research, epidemiological research, interdisciplinary clinical research into follow-up assessments and new treatment methods, development of new diagnostic methods including different neuroimaging techniques (MRI, DTI, MRS, fMRI), and research into ethical questions.
The research spans from emergency newborn treatment, continued follow-up from the infant stage and up to adult age. We have a particular focus on preterm born children, children with adverse influences during pregnancy (inhibited growth, infections, medicines, alcohol, nicotine, drugs), children with congenital brain damage, children who have experienced chronic or acute lack of oxygen before or during birth, and children who have been subjected to serious accidents or infection in the early years of childhood.
The research, which is the most extensive within the activities of the paediatric research groups at LBK, is organised into four topics:
- Cerebral palsy (CP) (Leader: Professor Torstein Vik)
- The Walking Easier (WE) study (St. Olavs Hospital)
- Animal research (Leader: Associate professor Marius Widerøe)
- Clinical long-term follow-up and imaging of the brain (Leader: Associate professor Kari Anne I. Evensen)
- Neonatal medical research (Leader: Associate professor Ragnhild Støen)
There is also considerable collaboration with other research groups, departments and faculties at NTNU, and different departments at St. Olavs Hospital, as well as with leading national and international research environments.